Suppr超能文献

低剂量与高剂量99mTc MIBI方案在原发性甲状旁腺功能亢进患者放射性引导手术中的有效性。

The effectiveness of low-dose versus high-dose 99mTc MIBI protocols for radioguided surgery in patients with primary hyperparathyroidism.

作者信息

Gencoglu Esra A, Aras Murat, Moray Gokhan, Aktas Ayse

机构信息

Departments of aNuclear Medicine bSurgery, Baskent University Medical Faculty, Ankara, Turkey.

出版信息

Nucl Med Commun. 2014 Apr;35(4):398-404. doi: 10.1097/MNM.0000000000000056.

Abstract

OBJECTIVE

The aim of this study was to compare the efficacy of low-dose and high-dose (99m)Tc methoxy isobutyl isonitrile (MIBI) protocols in intraoperative localization of parathyroid adenomas by means of a gamma probe in patients with primary hyperparathyroidism (PHPT).

PATIENTS AND METHODS

The study included 62 patients with PHPT who were divided into two groups. Group 1 consisted of 32 patients who were injected with a low dose (1 mCi) of (99m)Tc MIBI in the surgical suite 10 min before incision. Group 2 included 30 patients who were intravenously administered a high dose (15 mCi) of (99m)Tc MIBI 2 h before surgery. With the aid of a gamma probe, intraoperative localization of parathyroid adenomas was performed in both groups of patients who underwent minimally invasive parathyroidectomy. All lesions thought to be parathyroid adenomas were excised and subsequently evaluated histopathologically.

RESULTS

All parathyroid adenomas in both groups were localized and excised by means of an intraoperative gamma probe. The sensitivity, specificity, and accuracy of low-dose and high-dose (99m)Tc MIBI protocols in the intraoperative localization of adenomas in patients with PHPT were 100%.

CONCLUSION

In the light of these findings, we conclude that low-dose (99m)Tc MIBI may be preferred to intraoperative identification of parathyroid adenomas by means of a gamma probe in PHPT patients because it appears to be as effective as high-dose (99m)Tc MIBI. Moreover, the low-dose protocol does not have the disadvantages of high-dose protocol.

摘要

目的

本研究旨在比较低剂量和高剂量(99m)锝甲氧基异丁基异腈(MIBI)方案在原发性甲状旁腺功能亢进症(PHPT)患者中通过γ探头对甲状旁腺腺瘤进行术中定位的疗效。

患者与方法

该研究纳入62例PHPT患者,分为两组。第1组由32例患者组成,在手术切口前10分钟于手术室内注射低剂量(1毫居里)的(99m)Tc MIBI。第2组包括30例患者,在手术前2小时静脉注射高剂量(15毫居里)的(99m)Tc MIBI。在γ探头的辅助下,对两组接受微创甲状旁腺切除术的患者进行甲状旁腺腺瘤的术中定位。所有被认为是甲状旁腺腺瘤的病变均被切除,随后进行组织病理学评估。

结果

两组所有甲状旁腺腺瘤均通过术中γ探头定位并切除。低剂量和高剂量(99m)Tc MIBI方案在PHPT患者腺瘤术中定位的敏感性、特异性和准确性均为100%。

结论

根据这些发现,我们得出结论,在PHPT患者中,低剂量(99m)Tc MIBI在通过γ探头术中识别甲状旁腺腺瘤方面可能更受青睐,因为它似乎与高剂量(99m)Tc MIBI一样有效。此外,低剂量方案没有高剂量方案的缺点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验